SUMMARY Several diseases with autoimmune features have recently been shown to be characterised by defects in suppressor cell immune regulation. Aberrant immune mechanisms of primary importance have been sought but not yet demonstrated for idiopathic congestive cardiomyopathy and rheumatic heart disease. We tested whether defective immunoregulatory function might explain certain features of these diseases. Peripheral blood mononuclear cells from patients with both diseases showed normal proliferative responses in the mixed leucocyte reaction. Concanavalin A induced similar suppressor activity, quantified in mixed leucocyte reaction as a suppression index, among control subjects, patients with rheumatic heart disease, and patients with idiopathic congestive cardiomyopathy. Similarly, patient serum supported induction of suppressor activity in normal leucocytes equal to that of control serum. A chronic immunoregulatory defect thus does not appear necessary for the development of idiopathic congestive cardiomyopathy or rheumatic heart disease.
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The involvement of immunological reactions in several aspects of cardiac disease has become increasingly evident in recent years.' 2 Antiheart antibodies have been described in the postpericardiotomy and related syndromes,2 in infectious endocarditis,3 and in rheumatic fever and primary myocardial disease.2 4 5 Rejection of cardiac allografts in transplant patients is associated with activation of both humoral and cellular immune processes.2 6 Suppressor activity was induced by the addition of concanavalin A (con A) at a final concentration of 20 ,ug/ml to peripheral blood mononuclear suspensions followed by incubation for either 24 or 48 hours at 37°C in 5% humidified CO2-28 29 At the end of incubation, suppressor cells were irradiated to prevent replication (cobalt-60, 2000 rads/8 min). Parallel cultures without con A served as controls.
"Suppressed" and "simple" mixed leucocyte reactions consisted of six day microwell cultures (0-2 ml) containing equal numbers (105) of responder cells, irradiated allogeneic stimulator cells, and either the responder's con A-activated effector (suppressor) cells or his non-activated (control) cells, respectively.24 28 During the last 24 hours of incubation, 1 ,uCi/well of tritiated thymidine was added; cellular uptake of thymidine was measured by liquid scintillation by averaging four replicate wells. The-suppression index representing the percentage inhibition of,xesponder cell blastogenesis by con A-activated effector cells, Responder peripheral blood mononuclear leucocytes from control subjects and patients in both cardiac groups showed brisk proliferation reactions in the simple mononuclear leucocyte reactions (Fig.) . Substantial suppressor activity was also induced in peripheral blood mononuclear suspensions from control subjects and patients with rheumatic heart disease and congestive cardiomyopathy by addition of con A-activated autologous cells to the mononuclear leucocyte, xeactions (p<0001, control vs activated, Pig.) Net (Table) . In subjects A and B, con A itients with induced suppressor activity in sham-irradiated cells n a mean (suppression index 100%, 95%); in contrast, obvious range 41 to stimulation rather than suppression followed addition -26 Effects of selective elimination of suppressor cells from normal subjects on con A-activated mononuclear leucocyte reactions: In I, irradiation pretreatment is used to inactivate potential suppressor cells. In II, suppressor cell induction is blocked by chenodeoxycholic acid.
of preirradiated con A-treated effector cells to mononuclear leucocyte reactions (suppression index -333%, -100%). In subject C, con A induced suppressor activity in untreated peripheral blood mononuclear suspensions (suppression index 77%), but stimulation rather than suppression followed incubation with CDCA during con A-induction (n=3, mean suppression index -26.0%). Thus, elimination of suppressor activity resulted from pretreatments known to interrupt suppressor lymphocyte function, and unmasking of latent helper lymphocyte function was suggested by a subsequent increase in thymidine incorporation.
Discussion
We found normal immunoregulatory function, as assessed by inducible in vitro suppressor activity, in patients with idiopathic congestive cardiomyopathy and rheumatic heart disease. Of the common cardiac diseases, these have been most often mentioned as potentially involving immune mechanisms.2 5 Persistent reactivity to antigenic stimuli caused by defective immunoregulation might be postulated in these diseases. Our data, however, do not support an essential role for chronic immunoregulatory dysfunction. Other immune abnormalities and subtle or transient immunoregulatory defects cannot be excluded.
The ability to induce normal suppressor activity suggests that a suppressor cell population, presumably consisting of suppressor (T-y) lymphocytes and perhaps also monocytes, is present in these diseases. '6 7 Patient serum was also found to be devoid of factors inhibiting induction of suppressor activity. Dependence of suppression on a subpopulation of effector cells was confirmed by abolition of suppression by low-dose irradiation and bile acids, methods known selectively to eliminate suppressor T cells. 30 31 These experiments confirm that the assay can determine if a patient's suppressor-precursor population is either absent or functionally inhibited (as by serum factors) during the con A-induction period.
The finding of normal inducible suppressor activity in congestive cardiomyopathy contrasts with a recent report by Fowles et al.4 In that report, peripheral blood mononuclear suspensions from healthy subjects and patients with coronary artery disease but not congestive cardiomyopathy caused suppression of mononuclear leucocyte reactions. No patient with congestive cardiomyopathy in their series displayed a suppression index greater than 22% (mean suppression index -66%). In contrast, the suppression index in every patient with congestive cardiomyopathy in our series was greater than 20%. 
